A mouse cytomegalovirus glycoprotein retains MHC class I complexes in the ERGIC/cis-Golgi compartments

H Ziegler1, R Thale, P Lucin

  • 1Max von Pettenkofer Institut, Ludwig-Maximilians-Universitat, Munchen, Federal Republic of Germany.

Immunity
|January 1, 1997
PubMed

Insights

Mouse cytomegalovirus uses the m152 gene to block antigen presentation. This novel mechanism arrests the export of mouse MHC class I complexes, evading cytotoxic T cell detection.

Area of Science:

  • Virology
  • Immunology
  • Molecular Biology

Background:

  • Mouse cytomegalovirus (MCMV) employs immune evasion strategies to ensure viral replication.
  • MHC class I pathway presentation is crucial for adaptive immune responses, involving antigen processing and cell surface expression.
  • Understanding viral interference with antigen presentation is key to developing antiviral therapies.

Purpose of the Study:

  • To investigate the mechanism by which MCMV inhibits antigen presentation via the MHC class I pathway.
  • To identify the specific viral gene responsible for this immune evasion.
  • To characterize the function of the identified viral protein and its impact on host cell processes.

Main Methods:

  • Gene expression analysis of MCMV genes in infected murine and human cells.
  • Protein characterization of the identified viral glycoprotein (gp40).
  • Cellular localization studies and analysis of MHC class I complex transport using immunofluorescence and biochemical assays.
  • Cytotoxic T cell lysis assays to assess immune recognition.

Main Results:

  • The MCMV gene m152 was identified as responsible for blocking antigen presentation.
  • Expression of m152, encoding a 40 kDa glycoprotein (gp40), arrested the export of mouse MHC class I complexes from the ER-Golgi intermediate compartment.
  • This arrest inhibited lysis by cytotoxic T cells, while human MHC class I transport remained unaffected.
  • Deletion of the cytoplasmic tail of gp40 did not alter its effect on MHC class I export.

Conclusions:

  • MCMV utilizes the m152 gene product, gp40, to block antigen presentation through a novel mechanism.
  • This mechanism involves arresting MHC class I complex export from the ER-Golgi intermediate compartment, distinct from known viral immune evasion strategies.
  • The findings reveal a new herpesvirus strategy for shutting off MHC class I function, offering insights into viral pathogenesis and immune evasion.

Related Concept Videos

Intralumenal Vesicles and Multivesicular Bodies01:38

Intralumenal Vesicles and Multivesicular Bodies

Intraluminal vesicles (ILVs) are small vesicles 50-80 nm in diameter formed during the maturation of early endosomes. A specialized endosome containing numerous ILVs is called a multivesicular body (MVB). ILVs contain internalized molecules such as antigens, nucleic acids, proteins, and metabolites. Some of these molecules are released from the MVBs inside exosomes and are transported to other cells. Other MVBs contain molecules that are retained in the ILVs and are later degraded within the...
Export of Misfolded Proteins out of the ER01:32

Export of Misfolded Proteins out of the ER

After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...